In vitro susceptibility of Neisseria gonorrhoeae to netilmicin and etimicin in comparison to gentamicin and other aminoglycosides
European Journal of Clinical Microbiology & Infectious Diseases · 2024
DOI: 10.1007/s10096-024-04782-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Sonja Gross und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology, University of Zurich, Gloriastrasse 30, 8006, Zurich, Switzerland. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Gentamicins, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, University of Zurich.
Abstract (Originalsprache)
Purpose
Single doses of gentamicin have demonstrated clinical efficacy in the treatment of urogenital gonorrhea, but lower cure rates for oropharyngeal and anorectal gonorrhea. Formulations selectively enriched in specific gentamicin C congeners have been proposed as a less toxic alternative to gentamicin, potentially permitting higher dosing to result in increased plasma exposures at the extragenital sites of infection. The purpose of the present study was to compare the antibacterial activity of individual gentamicin C congeners against Neisseria gonorrhoeae to that of other aminoglycoside antibiotics.
Methods
Antimicrobial susceptibility of three N. gonorrhoeae reference strains and 152 clinical isolates was assessed using standard disk diffusion, agar dilution, and epsilometer tests.
Results
Gentamicin C1, C2, C1a, and C2a demonstrated similar activity against N. gonorrhoeae . Interestingly, susceptibility to the 1- N -ethylated aminoglycosides etimicin and netilmicin was significantly higher than the susceptibility to their parent compounds gentamicin C1a and sisomicin, and to any other of the 25 aminoglycosides assessed in this study. Propylamycin, a 4’-propylated paromomycin analogue, was significantly more active against N. gonorrhoeae than its parent compound, too.
Conclusion
Selectively enriched gentamicin formulations hold promise for a less toxic but equally efficacious alternative to gentamicin. Our study warrants additional consideration of the clinically established netilmicin and etimicin for treatment of genital and perhaps extragenital gonorrhea. Additional studies are required to elucidate the mechanism behind the advantage of alkylated aminoglycosides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology, University of Zurich, Gloriastrasse 30, 8006, Zurich, Switzerland.
- Private University in the Principality of Liechtenstein, Dorfstrasse 24, 9495, Triesen, Liechtenstein.
- Dr. Risch Medical Laboratory, Waldeggstrasse 37, 3097, Liebefeld, Switzerland.
- Department of Pharmaceutical and Biomedical Sciences, University of Georgia, 250 West Green Street, Athens, GA, 30602, USA.
- Institute of Medical Microbiology, University of Zurich, Gloriastrasse 30, 8006, Zurich, Switzerland. sven.hobbie@usb.ch.
- Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. sven.hobbie@usb.ch.
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- University of Zurich
Zitieren
APA
Gross, S., Herren, S., Gysin, M., Rominski, A., Roditscheff, A., Risch, M., Imkamp, F., Crich, D., & Hobbie, S. N. (2024). In vitro susceptibility of Neisseria gonorrhoeae to netilmicin and etimicin in comparison to gentamicin and other aminoglycosides. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04782-2
Vancouver
Gross S, Herren S, Gysin M, Rominski A, Roditscheff A, Risch M, et al. In vitro susceptibility of Neisseria gonorrhoeae to netilmicin and etimicin in comparison to gentamicin and other aminoglycosides. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04782-2
BibTeX
@article{Gross2024,
author = {Gross, Sonja and Herren, Sebastian and Gysin, Marina and Rominski, Anna and Roditscheff, Anna and Risch, Martin and Imkamp, Frank and Crich, David and Hobbie, Sven N},
title = {In vitro susceptibility of Neisseria gonorrhoeae to netilmicin and etimicin in comparison to gentamicin and other aminoglycosides},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
doi = {10.1007/s10096-024-04782-2}
}
EUVIMED